Stevanato Group S.p.A. (STVN) Insider Flynn Sells $26K of Stock
Karen Flynn sold 1,493 shares of Stevanato Group for approximately $25,515 on June 15, 2026.
Reviewed by automated data checks against the source filing. How we make and check alerts
Karen Flynn sold 1,493 shares of Stevanato Group S.p.A. ($STVN) at an average price of $17.09, worth about $25,515.37, on June 15, 2026. The trade was reported to the SEC in a Form 4 filing.
Since the trade, $STVN is up 1.9% after 1 week, up 13.7% after 1 month and up 13.7% to date (from the $16.63 close on Jun 15, 2026).
STVN
Stevanato Group S.p.A.
Key Points
- On June 15, 2026, Karen Flynn sold 1,493 shares of Stevanato Group S.p.A. for about $25,515, at a price of $17.09 each.
- Stevanato Group's stock closed at $18.39 on the day of the sale, down from the previous close of $19.31.
- Analysts currently maintain a Neutral rating on Stevanato Group with a price target of $23.00, down from $28.00.
Get $STVN trade alerts by text
We text you when insiders, Congress or big funds trade $STVN. Free.
Not investment advice. EarningsIQ is not a registered investment adviser, and this automated Stevanato Group S.p.A. alert may contain errors. Disclosures
Flynn's Recent Sale of Stevanato Shares
On June 15, 2026, Karen Flynn sold 1,493 shares of Stevanato Group S.p.A. (NYSE: STVN) for about $25,515, at a price of $17.09 per share. This sale comes as the stock was trading at $18.39, which reflects a decline from the previous close of $19.31.
Recent Insider Activity
Flynn's sale follows a flurry of insider activity at Stevanato Group. On June 9, Mauro Stocchi, the Chief Business Strategy Officer, sold 6,586 shares. The same day, he also bought 6,586 shares, indicating a mix of confidence and liquidity needs. On June 12, other insiders, including Sue-Jean Lin and Elisabetta Magistretti, purchased 4,975 shares each, while Chief Financial Officer Dal Lago Marco sold 7,997 shares. This pattern of buying and selling among insiders suggests ongoing adjustments to their positions.
Stock Performance Context
Stevanato Group's stock has been fluctuating, with a 52-week low of $12.89 and a high of $27.99. The stock's current trading level is above its 200-day moving average of $18.19 but below the 50-day moving average of $20.98. The recent insider transactions may influence market perceptions as they reflect the insiders' views on the stock's future potential.
Analysts Set New Price Targets
On September 9, 2026, UBS maintained a Neutral rating on Stevanato Group, lowering its price target from $28.00 to $23.00. The consensus among analysts indicates a buy recommendation, with a mean target price of $24.47 based on 13 opinions. This suggests that while there are concerns reflected in the price target adjustment, analysts still see potential in the stock.
About Stevanato Group
Stevanato Group S.p.A. is a company that designs and manufactures products for the biopharma and healthcare industries. Its offerings include drug delivery systems and diagnostic solutions, serving a global market. The recent insider trades may reflect their strategic positions as the company navigates a competitive landscape.
What to Watch at Stevanato Group S.p.A.
Investors should keep an eye on the upcoming earnings report scheduled for November 5, 2026. The recent insider trading activity, particularly Flynn's sale, highlights the dynamic nature of ownership at Stevanato Group. Remember, the details from this insider sale reflect positions as of June 15, 2026, and may not represent current holdings.
Related Filing Alerts
Source: Karen Flynn's Form 4 filing on $STVN (Jun 15, 2026). Find the original filing: STVN Form 4 filings on SEC EDGAR. Written by software, not financial advice. How we make alerts